Michael First, M.D.
Professor of Clinical Psychiatry
Research Psychiatrist, New York State Psychiatric Institute
Associate, Forensic Panel
Consultant on ICD-11 revision
World Health Organization (WHO)
Michael B. First M.D., is a Professor of Clinical Psychiatry at Columbia University, is a Research Psychiatrist at the Biometrics Department at the New York State Psychiatric Institute, maintains a schematherapy and psychopharmacology practice in Manhattan,and conducts forensic evaluations and consultations on a wide range of criminal and civil matters.
- Dr. First is a nationally and internationally recognized expert on psychiatric diagnosis and assessment issues.
- Dr. First was co-principal investigator on the “Future of Psychiatric Diagnosis” conferences that developed research agendas for the upcoming DSM-V and ICD-11 revisions and was director of the DSM-V Prelude Project and is a consultant to the World Health Organization regarding the revision of ICD-11.
- Dr. First is the Editor of the DSM-IV-TR, the Editor of Text and Criteria for DSM-IV, the DSM-IV Primary Care Version, and the APA’s Handbook on Psychiatric Measures.
- He has co-authored and co-edited a number of books, including A Research Agenda for DSM-V, Advancing DSM: Dilemmas in Psychiatric Diagnosis, Clinical Guide to the Diagnosis and Treatment of Mental Disorders, DSM-IV-TR Guidebook, DSM-IV-TR Handbook for Differential Diagnosis, Structured Clinical Interview for DSM-IV (SCID), DSM-IV-TR Casebook, Treatment Companion to the DSM-IV-TR Casebook, and various software packages.
- He has trained thousands of clinicians and researchers in diagnostic assessment and differential diagnosis.
- He has provided expert opinion and testimony on several high profile cases including the federal trial of the accused Al Qaeda terrorist Zacarias Moussaoui.
Dr. Gold’s deposition testimony there is currently no Wikipedia entry for Dr. Gold
Dr. First’s response to Dr. Gold, KSBHA expert, re: misrepresentations of the DTREE program.
Of additional interest, Dr. Gold testified under oath* that she had only just looked at the DTREE program a couple days prior to the hearing. She had not even seen it at the time of her deposition.
*The hearing transcript is embargoed until Monday, March 6, but will be available for review here then.
For the erudite among you, read some of Dr. First’s publications.* He has pointed out that psychiatrists are not at all in agreement as to the proper use of the DSM IV-TR. Some do not even use it at all. Dr. First heads up the committee to research and produce the next major revision, DSM-V.
In personal communications with Dr. Neuhaus, he has commented that the manner in which she used the DTREE and GAF computer programs was completely consistent with its design purposes. This has been grossly misrepresented in Gaschler’s Initial Finding as consisting merely of checking “yes/no answers” and implying that Dr. Neuhaus had not even seen some of the patients. Dr. Neuhaus had the option of calling the patients in question as witnesses but refused in order to protect their privacy
- Dr. First’s fee to review Dr. Gold’s deposition and report = $0
- Dr. Gold’s fee to the citizens of Kansas (now Dr. Neuhaus) = $100,000?
* A few relevant publications
- Kupfer DA, First MB, Regier DA (2002). A Research Agenda for DSM-V. American Psychiatric Publishing, ISBN 9780890422922
- First MB, Pincus HA, Levine JB, Williams JB, Ustun B, Peele R (2004). Clinical utility as a criterion for revising psychiatric diagnoses. Am J Psychiatry. 2004 Jun;161(6):946-54. PMID 15169680
- First MB, Westen D (2007). Classification for clinical practice: how to make ICD and DSM better able to serve clinicians. International Review of Psychiatry. 2007;19: 473-481. PMID 17896228
- First MB, Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM-IV (SCID-I) – Research Version, Biometrics Research, New York, NY, USA